Drugs for Neglected Diseases initiative

One dose. No hospitalization. @TV5MONDEINFO travelled to Kasai, DRC, to meet former patients & healthcare workers using acoziborole, our new treatment for sleeping sickness. Their reportage shows how it could transform care & help eliminate this disease.⤵️ youtube.com/watch?v=lz4R2r…

“Acoziborole allows us to go as close as possible to the affected people,” says @DNDi's Wilfried Mutombo (@kalonji_mutombo) A single-dose pill could transform sleeping sickness treatment in Africa. scidev.net/global/explain…

Introducing Médecins Sans Frontières (MSF) South Asia Without Borders Media Fellowship mentors for the 2025-2026 cohort, each bringing expertise and lived experience across journalism, public health, climate, and social justice. 🔹 @KotwalMeena is the Founder and Editor-in-Chief of @The_Mooknayak, and an award-winning journalist whose work centres on caste, gender, and social justice, amplifying marginalised voices across India. 🔹 Krishnendu Bandhyopadhyay is the Environment Editor at @timesofindia, Kolkata, leading science-based reporting on climate change, biodiversity, and environmental governance. 🔹@JamwalNidhi (@DNDi mentor) is an award-winning independent journalist with over 25 years of experience reporting on climate, environment, health, and rural issues, and is widely recognised for amplifying gendered perspectives in climate action. 🔹 Abhijit Roy is a public health professional and Regional Access Senior Manager at @GARDP, working at the intersection of health systems, access to medicines, and antimicrobial resistance to advance equitable, country-led solutions. Our mentors will guide fellows with insight and a strong commitment to equity and impact. Learn more: msfsouthasia.org/without-border… #MSFSouthAsia #WithoutBordersMediaFellowship

@EDCTP3 @EMA_News @EDCTP We are very appreciative of the funding that EDCTP and many other donors and in-kind partners provided in the development of this game-changing treatment for sleeping sickness. Such long-term support makes R&D innovation possible!

A single-dose oral treatment for sleeping sickness, supported by #EDCTP, has been approved by @EMA_News. 💊 Projects ACOZI-KIDS and StrogHAT, funded by @EDCTP and @EDCTP3, are ensuring at-risk communities benefit from this innovation. 🔗 More: global-health-edctp3.europa.eu/news-and-event…

🐟 Liliane travels every day to the fish farms near her village in the DRC. One day, she noticed that her trips were getting harder. She had contracted sleeping sickness after being bitten by tsetse flies that live in these wetlands. #1Dose1Cure

Working in medicine or clinical sciences in the #Americas? Ever heard of #Chagas Disease? Spread by Kissing Bugs, this parasite causes serious problems leading to heart disease, gastric problems and death. CHECK FOR CHAGAS youtu.be/JvaFWEKOmBg @The_MRC @durham_uni @DNDi

🎉 Fantastic news shared by Wilfried Mutombo Kalonji, who participated in TDR's clinical research fellowship at @DNDi and has contributed to a major milestone in the fight against sleeping sickness: bit.ly/4tYk8oj

🐍Snakebites affect 1.8-2.7 million people each year. The disease is deeply neglected and patients need better access to antivenoms. A Global Snakebite Taskforce report urges on govs and funders to invest, including in R&D. By @scidevafrique [in French] scidev.net/afrique-sub-sa…

“Aunque enfermedades como el cólera sean urgentes en el país, las ETD no pueden ignorarse. No son agudas, pero en dos o tres años podrían provocar amputaciones o muertes si no se tratan”, resume Borna Nyaoke-Anoke, responsable de micetoma en @DNDi elpais.com/planeta-futuro…

@DNDi 🟩  Un paso histórico contra la enfermedad del sueño: primera terapia en dosis única 👇🏽 msf.es/noticia/paso-h…

In 2014, I visited eastern DRC, where @MSF teams were treating sleeping sickness - the only available drug was so toxic it killed 1 in 20 patients. In 2026 I'm so proud that, thanks to @DNDi, patients can be cured with a single dose of a groundbreaking new oral drug, acoziborole.

‘I tell African women: we are capable of working in science. It’s not just for men.’ For #IWD2026, we spotlight Dr Hélène, a Congolese researcher who has dedicated her career to fighting neglected diseases in the DRC. #1Dose1Cure #GiveToGain #GlobalHealth

In 2014, Javid @MSF_IP, traveled to a remote corner of the DRC to visit an @MSF sleeping sickness programme. What he witnessed there mirrored what MSF doctors saw over 20 years ago when they called to create DNDi – medical neglect. #1Dose1Cure #BeatNTDs

@novonordiskfond renewed its support to DNDi & @THSTIFaridabad to advance the development of a novel broad‑spectrum antiviral candidate targeting influenza & other viruses of pandemic potential. 👉 bit.ly/3OIAYrn

@sanofi Thank you @sanofi for the close partnership to deliver innovative new treatments for people with sleeping sickness and put the elimination of this neglected disease within reach! 💊🧡

Together with @DNDi and FoundationS, we’re proud to receive a positive CHMP (Committee for Medicinal Products for Human Use) opinion from the European Medicines Agency for our new treatment for adults and adolescents with early and advanced stage gambiense sleeping sickness. This recommendation paves the way to bring innovative treatment to people affected by this deadly disease and aligns with the World Health Organization’s goal of eliminating gambiense sleeping sickness by 2030. We remain committed to advancing scientific innovation to address unmet patient needs, particularly vulnerable communities. Read our press release ➡️ spkl.io/6019AauOV #ActForPatients #FoundationS #DNDi #GlobalHealth #SleepingSickness

@KEMRI_Kenya @sanofi Thank you @KEMRI_Kenya for your unwavering support as one of our Founding Partners. This scientific breakthrough showcases the transformative power of science and partnership to deliver innovative solutions for the most neglected. 🔬🧡

@Stephen_Cornish @sanofi Thank you for sharing this scientific breakthrough for patients, an innovation that puts the elimination of sleeping sickness within reach! 🧡

EUREKA!! @DNDi & partners (including @sanofi ) took up the challenge to replace the painful & often deadly treatment & perseverance has paid off! A single dose non hospital cure has received a positive scientific opinion for a single dose of Acoziborole! Bravo to all involved!

@MSF Thank you @MSF for your unwavering support reaching this historic milestone for sleeping sickness! 🧡

Congrats to our partner @DNDi on the approval of their drug acoziborole to treat sleeping sickness! 🎉 This neglected disease could now be cured with a safe, single-dose pill, rather than complicated, toxic treatments that have previously been used.

@MSF_EastAfrica @EMA_News @sanofi Thank you @MSF_EastAfrica for your unwavering support reaching this historic milestone for sleeping sickness! 🧡

💊The 1st single‑dose treatment for sleeping sickness has received a positive opinion from @EMA_News. We are proud to have contributed to its development with @DNDi & @sanofi - a pill that could transform care & bring us closer to disease elimination. bit.ly/dndi-acozi

@sanofi @EMA_News 🤝 This achievement reflects over a decade of collaboration and innovation across the global health community. We thank our partners, donors, staff & everyone who was involved in making the dream of a single-dose, oral treatment for sleeping sickness come true.

🚀 Huge news for people living with #sleepingsickness! Acoziborole, a one-day, single-dose oral treatment developed with @sanofi, has received a positive opinion from @EMA_News for the treatment of the most common form of sleeping sickness. 👉bit.ly/4rDnDil #beatNTDs